Cargando…
Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4(+) T cells
CD4(+) T cells play a critical role in antitumor immunity via recognition of peptide antigens presented on MHC class II (MHC-II). Although some solid cancers can be induced to express MHC-II, the extent to which this enables direct recognition by tumor-specific CD4(+) T cells is unclear. We isolated...
Autores principales: | Brightman, Spencer E., Naradikian, Martin S., Thota, Rukman R., Becker, Angelica, Montero, Leslie, Bahmanof, Milad, Premlal, Ashmitaa Logandha Ramamoorthy, Greenbaum, Jason A., Peters, Bjoern, Cohen, Ezra E.W., Miller, Aaron M., Schoenberger, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977289/ https://www.ncbi.nlm.nih.gov/pubmed/36512410 http://dx.doi.org/10.1172/jci.insight.165570 |
Ejemplares similares
-
Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors
por: Brightman, Spencer E., et al.
Publicado: (2023) -
Author Correction: Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors
por: Brightman, Spencer E., et al.
Publicado: (2023) -
Linked CD4(+)/CD8(+) T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
por: Dolina, Joseph S., et al.
Publicado: (2023) -
Predicting T cell recognition of MHC class I restricted neoepitopes
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2018) -
Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2022)